UNIVERSAL DISPLAY CORP \PA\ — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that UNIVERSAL DISPLAY CORP \PA\ filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $650.61M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $647.68M | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $576.43M | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $616.62M | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $553.53M | Feb 22, 2024 |
| FY2020 | Dec 31, 2020 | $141.54M | Feb 18, 2021 |
| FY2020 | Sep 30, 2020 | $117.08M | Feb 18, 2021 |
| FY2020 | Jun 30, 2020 | $57.97M | Feb 18, 2021 |
| FY2020 | Mar 31, 2020 | $112.28M | Feb 18, 2021 |
| FY2020 | Dec 31, 2019 | $101.73M | Feb 18, 2021 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $650.61M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $647.68M | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $576.43M | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $616.62M | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $553.53M | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $428.87M | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $405.18M | Feb 23, 2022 |
| FY2020 | Dec 31, 2018 | $247.41M | Feb 18, 2021 |
| FY2019 | Dec 31, 2017 | $335.63M | Feb 20, 2020 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $496.49M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $499.22M | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $441.05M | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $488.72M | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $438.53M | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $343.39M | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $329.80M | Feb 23, 2022 |
| FY2020 | Dec 31, 2018 | $193.87M | Feb 18, 2021 |
| FY2019 | Dec 31, 2017 | $280.93M | Feb 20, 2020 |
| FY2018 | Dec 31, 2016 | $172.60M | Feb 21, 2019 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $242.08M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $222.08M | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $203.01M | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $210.06M | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $184.21M | Feb 22, 2024 |
| FY2020 | Dec 31, 2020 | $53.90M | Feb 18, 2021 |
| FY2020 | Sep 30, 2020 | $40.50M | Feb 18, 2021 |
| FY2020 | Jun 30, 2020 | $815.0K | Feb 18, 2021 |
| FY2020 | Mar 31, 2020 | $38.16M | Feb 18, 2021 |
| FY2020 | Dec 31, 2019 | $26.43M | Feb 18, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $248.58M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $238.80M | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $217.19M | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $267.11M | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $227.64M | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $157.53M | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $158.34M | Feb 23, 2022 |
| FY2020 | Dec 31, 2018 | $56.74M | Feb 18, 2021 |
| FY2019 | Dec 31, 2017 | $146.25M | Feb 20, 2020 |
| FY2018 | Dec 31, 2016 | $68.41M | Feb 21, 2019 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $146.10M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $157.19M | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $130.48M | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $117.06M | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $99.67M | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $83.89M | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $71.28M | Feb 23, 2022 |
| FY2020 | Dec 31, 2018 | $53.72M | Feb 18, 2021 |
| FY2019 | Dec 31, 2017 | $49.14M | Feb 20, 2020 |
| FY2018 | Dec 31, 2016 | $42.74M | Feb 21, 2019 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $74.32M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $74.29M | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $67.39M | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $77.89M | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $80.37M | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $61.35M | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $59.61M | Feb 23, 2022 |
| FY2020 | Dec 31, 2018 | $47.00M | Feb 18, 2021 |
| FY2019 | Dec 31, 2017 | $46.81M | Feb 20, 2020 |
| FY2018 | Dec 31, 2016 | $32.88M | Feb 21, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $210.83M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $253.74M | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $154.78M | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $126.82M | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $191.11M | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $148.79M | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $193.91M | Feb 23, 2022 |
| FY2020 | Dec 31, 2018 | $121.80M | Feb 18, 2021 |
| FY2019 | Dec 31, 2017 | $133.37M | Feb 20, 2020 |
| FY2018 | Dec 31, 2016 | $80.34M | Feb 21, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $56.47M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $42.64M | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $59.79M | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $42.50M | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $43.16M | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $27.99M | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $30.06M | Feb 23, 2022 |
| FY2020 | Dec 31, 2018 | $25.39M | Feb 18, 2021 |
| FY2019 | Dec 31, 2017 | $29.80M | Feb 20, 2020 |
| FY2018 | Dec 31, 2016 | $7.30M | Feb 21, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.96B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $1.83B | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | $1.67B | Feb 20, 2025 |
| FY2023 | Dec 31, 2022 | $1.53B | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | $1.47B | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $1.27B | Feb 23, 2022 |
| FY2020 | Dec 31, 2019 | $1.12B | Feb 18, 2021 |
| FY2019 | Dec 31, 2018 | $933.42M | Feb 20, 2020 |
| FY2018 | Dec 31, 2017 | $779.96M | Feb 21, 2019 |
| FY2017 | Dec 31, 2016 | $627.56M | Feb 22, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $202.74M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $215.81M | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | $221.74M | Feb 20, 2025 |
| FY2023 | Dec 31, 2022 | $257.45M | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | $367.01M | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $356.51M | Feb 23, 2022 |
| FY2020 | Dec 31, 2019 | $308.71M | Feb 18, 2021 |
| FY2019 | Dec 31, 2018 | $242.92M | Feb 20, 2020 |
| FY2018 | Dec 31, 2017 | $120.90M | Feb 21, 2019 |
| FY2017 | Dec 31, 2016 | $99.09M | Feb 22, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.76B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $1.62B | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $1.45B | Feb 19, 2026 |
| FY2025 | Dec 31, 2022 | $1.28B | Feb 19, 2026 |
| FY2024 | Dec 31, 2021 | $1.10B | Feb 20, 2025 |
| FY2023 | Dec 31, 2020 | $912.71M | Feb 22, 2024 |
| FY2022 | Dec 31, 2019 | $811.45M | Feb 23, 2023 |
| FY2021 | Dec 31, 2018 | $690.51M | Feb 23, 2022 |
| FY2020 | Dec 31, 2017 | $659.05M | Feb 18, 2021 |
| FY2019 | Dec 31, 2016 | $528.47M | Feb 20, 2020 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $15.54M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $15.54M | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | $15.54M | Feb 20, 2025 |
| FY2023 | Dec 31, 2022 | $15.54M | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | $15.54M | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $15.54M | Feb 23, 2022 |
| FY2020 | Dec 31, 2019 | $15.54M | Feb 18, 2021 |
| FY2019 | Dec 31, 2018 | $15.54M | Feb 20, 2020 |
| FY2018 | Dec 31, 2017 | $15.54M | Feb 21, 2019 |
| FY2017 | Dec 31, 2016 | $15.54M | Feb 22, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.09B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $934.66M | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | $789.55M | Feb 20, 2025 |
| FY2023 | Dec 31, 2022 | $653.28M | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | $500.21M | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $353.93M | Feb 23, 2022 |
| FY2020 | Dec 31, 2019 | $249.00M | Feb 18, 2021 |
| FY2019 | Dec 31, 2018 | $129.55M | Feb 20, 2020 |
| FY2018 | Dec 31, 2017 | $99.13M | Feb 21, 2019 |
| FY2017 | Dec 31, 2016 | ($25.56M) | Feb 22, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $138.35M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $98.98M | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | $91.99M | Feb 20, 2025 |
| FY2023 | Dec 31, 2022 | $93.43M | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | $311.99M | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $630.01M | Feb 23, 2022 |
| FY2020 | Dec 31, 2019 | $131.63M | Feb 18, 2021 |
| FY2019 | Dec 31, 2018 | $211.02M | Feb 20, 2020 |
| FY2018 | Dec 31, 2017 | $132.84M | Feb 21, 2019 |
| FY2018 | Dec 31, 2016 | $139.37M | Feb 21, 2019 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 5 | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | 4 | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | 4 | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | 4 | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | 3 | Feb 22, 2024 |
| FY2020 | Dec 31, 2020 | 1 | Feb 18, 2021 |
| FY2020 | Sep 30, 2020 | 0 | Feb 18, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Feb 18, 2021 |
| FY2020 | Mar 31, 2020 | 0 | Feb 18, 2021 |
| FY2020 | Dec 31, 2019 | 0 | Feb 18, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 5 | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | 4 | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | 4 | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | 4 | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | 3 | Feb 22, 2024 |
| FY2020 | Dec 31, 2020 | 1 | Feb 18, 2021 |
| FY2020 | Sep 30, 2020 | 0 | Feb 18, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Feb 18, 2021 |
| FY2020 | Mar 31, 2020 | 0 | Feb 18, 2021 |
| FY2020 | Dec 31, 2019 | 0 | Feb 18, 2021 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 47.26M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | 47.47M | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | 47.37M | Feb 20, 2025 |
| FY2023 | Dec 31, 2022 | 47.77M | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | 47.70M | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | 47.65M | Feb 23, 2022 |
| FY2020 | Dec 31, 2019 | 47.49M | Feb 18, 2021 |
| FY2019 | Dec 31, 2018 | 47.32M | Feb 20, 2020 |
| FY2018 | Dec 31, 2017 | 47.12M | Feb 21, 2019 |
| FY2017 | Dec 31, 2016 | 46.91M | Feb 22, 2018 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $85.50M | Feb 19, 2026 |
| FY2024 | Dec 31, 2024 | $76.20M | Feb 20, 2025 |
| FY2023 | Dec 31, 2023 | $66.70M | Feb 22, 2024 |
| FY2022 | Dec 31, 2022 | $57.00M | Feb 23, 2023 |
| FY2021 | Dec 31, 2021 | $37.9K | Feb 23, 2022 |
| FY2020 | Dec 31, 2020 | $28.40M | Feb 18, 2021 |
| FY2019 | Dec 31, 2019 | $18.90M | Feb 20, 2020 |
| FY2018 | Dec 31, 2018 | $11.30M | Feb 21, 2019 |
| FY2017 | Dec 31, 2017 | $5.70M | Feb 22, 2018 |